The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Solid set of results given political circumstances, you just need to look 12 months ahead, with close to two mines online and soon to be producing over 200k ounces of gold market cap should easily be over £300m. Happy to hold this position given US money printing exercise and projected gold price.
Presentation on their site is very detailed and worth checking out. Disappointing Hummingbird are late to update the market with progress on Dugbe. PR non existent, lucky for us numbers will eventually do the talking.
I don't see how this will reach 40p in 2020. We need a decent H2 result and evidence that the new strategy is making a difference in H1 2021 and only then I see a reason for SP to head towards 40p.
If your target is short term share increase I guess you'll be disappointed. Better try your luck elsewhere. Long term I think this is a decent bet but you need to give it time.
Volume almost 8m already today? Must be transfer of holding between institutions. Started looking at this in recent weeks and slowly building position.
Profit warning? Think you're posting on the wrong board?
Furthermore the income from the sale of the two non-core assets could easily produce dividend covering current market cap.
If you want to read impressive H1 results come back in a year's time but the SP will be over 30p :)
I suggest you look at what's ahead. Foundations have been placed.
- Cash balance to double by year end.
- Quarantine clinic to be fully booked for 2 years for convention trials. 20% utilisation to date produced €15m of revenue.
- Covid-19 trials cost >£7m and we'll be fully booked with those at the second to be announced quarantine clinic.
- Monetise two of our non-core assets, the 49% stake in Imutex and the 62.6% stake in PrEP.
- Open Orphan data platform commercialisation in Q4, with some of the world's largest wearable companies for disease progression data.
The covid trials are major upside here that's not priced in, expect government announcement on those soon and then watch the SP.
Remember they paid to produce chim and the site was actually closed for number of weeks during covid in between trials. Utilisation ahead is the key for me.
Corrected link:
http://www.moepp.gov.mk/?nastani=????????-????????-??-????????-????
Good spot, official txt here. Definitely not a multi million impact as feared by some.
http://www.moepp.gov.mk/?nastani=????????-????????-??-????????-????
Interesting article. If you wanted to enter the UK market I'd say metro are the perfect acquisition target.
https://www.simplybusiness.co.uk/knowledge/articles/2020/06/best-business-bank-account-and-business-bank/
Was meant to say testing will be done via channel partners, GP networks, health clinics and private hospitals. Similar how you get a flu jab via your work (large employers).
channel partners to make testing available through GP networks, health clinics and private hospitals.
This has to be one of the best gold plays out there. If they can maintain production this should be challenging all time highs in the coming weeks. Q1 update will probably entice more from the sidelines.
The actual statement was
"We have run a downside sensitivity forecast at $18/bbl for the remainder of 2020 and $37/bbl for 2021 with a 20% reduction in production to cater for any impacts of COVID-19 or other operational issues. Excluding discretionary capital expenditure but including abandonment expenditure, the Group remains cash flow positive."
RRE can still generate cash flow at $18/bbl due to their Gas OPEX at $12, favorable Gas hedges and don't forget RRE has interest in the SAGE, Brae-Forties and WASPS infrastructure providing additional tariff income. Oil OPEX in 2020 is forecasted below $30 and even lower if forties is not taken offline this year for maintenance.
If I was going to dump 1m shares I doubt I'll get 5.9 offer for it. To be honest not sure what's going on. Either background buyer mopping up shares or off market transaction to help get seller out. But that's a relatively favorable price for the seller, doesn't make sense.
Price of oil might even help them get a producing portfolio of assets. We know there are players looking to exit and we know JM had support from investment banks to acquire Ophir. Why would JM take (and I agree questionable bonus) payment in shares when we could of taken cash.
Hopefully the old dog still has a trick up his sleeve and we'll hear something soon. CPR any day now but my interest is in the deals yet to be announced. JM has been buying shares, and confirmed he would buy at this level if allowed. The fact that he is not buying tells me he may well be negotiating something.
West Natuna Exploration Limited (WNEL) owns a 100% stake in the Duyung PSC. WNEL is owned by Conrad Petroleum (90%) and Empyrean Energy (10%). Conrad Petroleum is the operator of the field.
Whether you own 15% of WNEL or 15% of the asset directly the underlying asset has the same value. Your interest in the asset can be sold or bought in the same way.
I would have preferred they got straight Cash offer for the Italian asset but in the scheme of things those assets are not strategic.
7m in the bank and Duyung potential worth around $30m once FDP approved. What will bring shareholders real value is the assets they can further acquire in Asia. JM has a plan, can he deliver is the bet.
It was James Menzies who attracted me initially to follow this story and COROs attempt to acquire Ophir is when I really took note. After some research I believe there are interesting opportunities out there now in South East Asia where majors are looking to exit. Some of the characters you mentioned I'm not sure how much say or input they have in the direction CORO is taking, hopefully in time they will be asked to move on. Look at the recent appointment of Dr Nick Cooper and his past experience. This tells me the direction the company is taking. The previous funding arranged can be seen as expensive but it wasn't dilution at 2p level and it's what they do with the cash that matters. If they can increase resources, get sales contracts over the line and borrow dept again the assets for development then it will be seen as a decent arrangement.
I have a feeling it's the next deal that will be the real company maker. Petronas have no interest in developing small or even medium sized fields, smaller players are ideal to extract value from these or even marginal production fields.